vs
Acadia Healthcare Company, Inc.（ACHC）与Fabrinet（FN）财务数据对比。点击上方公司名可切换其他公司
Fabrinet的季度营收约是Acadia Healthcare Company, Inc.的1.4倍（$1.1B vs $821.5M），Fabrinet净利率更高（9.9% vs -143.3%，领先153.3%），Fabrinet同比增速更快（35.9% vs 6.1%），Fabrinet自由现金流更多（$-5.3M vs $-179.5M），过去两年Fabrinet的营收复合增速更高（24.4% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Fabrinet（股票代码FN）为标普中型股400指数成分股。该指数由标普道琼斯指数公司维护，覆盖400家以美企为主的中等市值企业，若成分企业存在多类流通股，指数的成分股总量有时会超过400只。
ACHC vs FN — 直观对比
营收规模更大
FN
是对方的1.4倍
$821.5M
营收增速更快
FN
高出29.8%
6.1%
净利率更高
FN
高出153.3%
-143.3%
自由现金流更多
FN
多$174.1M
$-179.5M
两年增速更快
FN
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $1.1B |
| 净利润 | $-1.2B | $112.6M |
| 毛利率 | — | 12.2% |
| 营业利润率 | -142.4% | 10.1% |
| 净利率 | -143.3% | 9.9% |
| 营收同比 | 6.1% | 35.9% |
| 净利润同比 | -3710.4% | 30.0% |
| 每股收益（稀释后） | $-12.98 | $3.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFN
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $978.1M | ||
| Q2 25 | $869.2M | $909.7M | ||
| Q1 25 | $770.5M | $871.8M | ||
| Q4 24 | $774.2M | $833.6M | ||
| Q3 24 | $815.6M | $804.2M | ||
| Q2 24 | $796.0M | $753.3M | ||
| Q1 24 | $768.1M | $731.5M |
净利润ACHCFN
| Q4 25 | $-1.2B | $112.6M | ||
| Q3 25 | $36.2M | $95.9M | ||
| Q2 25 | $30.1M | $87.2M | ||
| Q1 25 | $8.4M | $81.3M | ||
| Q4 24 | $32.6M | $86.6M | ||
| Q3 24 | $68.1M | $77.4M | ||
| Q2 24 | $78.5M | $81.1M | ||
| Q1 24 | $76.4M | $80.9M |
毛利率ACHCFN
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 12.4% |
营业利润率ACHCFN
| Q4 25 | -142.4% | 10.1% | ||
| Q3 25 | 4.7% | 9.6% | ||
| Q2 25 | 5.8% | 9.8% | ||
| Q1 25 | 1.7% | 9.0% | ||
| Q4 24 | 4.9% | 9.5% | ||
| Q3 24 | 12.1% | 9.6% | ||
| Q2 24 | 13.4% | 9.7% | ||
| Q1 24 | 12.9% | 9.7% |
净利率ACHCFN
| Q4 25 | -143.3% | 9.9% | ||
| Q3 25 | 4.3% | 9.8% | ||
| Q2 25 | 3.5% | 9.6% | ||
| Q1 25 | 1.1% | 9.3% | ||
| Q4 24 | 4.2% | 10.4% | ||
| Q3 24 | 8.4% | 9.6% | ||
| Q2 24 | 9.9% | 10.8% | ||
| Q1 24 | 9.9% | 11.1% |
每股收益（稀释后）ACHCFN
| Q4 25 | $-12.98 | $3.11 | ||
| Q3 25 | $0.40 | $2.66 | ||
| Q2 25 | $0.33 | $2.41 | ||
| Q1 25 | $0.09 | $2.25 | ||
| Q4 24 | $0.36 | $2.38 | ||
| Q3 24 | $0.74 | $2.13 | ||
| Q2 24 | $0.85 | $2.22 | ||
| Q1 24 | $0.83 | $2.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $960.8M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $2.2B |
| 总资产 | $5.5B | $3.3B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCFN
| Q4 25 | $133.2M | $960.8M | ||
| Q3 25 | $118.7M | $968.8M | ||
| Q2 25 | $131.4M | $934.2M | ||
| Q1 25 | $91.2M | $950.7M | ||
| Q4 24 | $76.3M | $934.6M | ||
| Q3 24 | $82.1M | $908.9M | ||
| Q2 24 | $77.2M | $858.6M | ||
| Q1 24 | $77.3M | $794.0M |
总债务ACHCFN
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
股东权益ACHCFN
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.0B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.8B | ||
| Q2 24 | $3.0B | $1.7B | ||
| Q1 24 | $2.9B | $1.7B |
总资产ACHCFN
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $2.8B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $6.0B | $2.5B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $5.7B | $2.3B | ||
| Q1 24 | $5.5B | $2.2B |
负债/权益比ACHCFN
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $46.3M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $-5.3M |
| 自由现金流率自由现金流/营收 | -21.8% | -0.5% |
| 资本支出强度资本支出/营收 | 11.3% | 4.6% |
| 现金转化率经营现金流/净利润 | — | 0.41× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $102.3M |
8季度趋势，按日历期对齐
经营现金流ACHCFN
| Q4 25 | $-86.3M | $46.3M | ||
| Q3 25 | $73.2M | $102.6M | ||
| Q2 25 | $133.5M | $55.1M | ||
| Q1 25 | $11.5M | $74.2M | ||
| Q4 24 | $116.7M | $115.9M | ||
| Q3 24 | $163.1M | $83.2M | ||
| Q2 24 | $171.1M | $83.1M | ||
| Q1 24 | $-321.3M | $100.9M |
自由现金流ACHCFN
| Q4 25 | $-179.5M | $-5.3M | ||
| Q3 25 | $-63.0M | $57.3M | ||
| Q2 25 | $-34.2M | $4.7M | ||
| Q1 25 | $-163.2M | $45.7M | ||
| Q4 24 | $-86.8M | $94.0M | ||
| Q3 24 | $-27.1M | $62.9M | ||
| Q2 24 | $16.9M | $70.4M | ||
| Q1 24 | $-463.7M | $87.3M |
自由现金流率ACHCFN
| Q4 25 | -21.8% | -0.5% | ||
| Q3 25 | -7.4% | 5.9% | ||
| Q2 25 | -3.9% | 0.5% | ||
| Q1 25 | -21.2% | 5.2% | ||
| Q4 24 | -11.2% | 11.3% | ||
| Q3 24 | -3.3% | 7.8% | ||
| Q2 24 | 2.1% | 9.3% | ||
| Q1 24 | -60.4% | 11.9% |
资本支出强度ACHCFN
| Q4 25 | 11.3% | 4.6% | ||
| Q3 25 | 16.0% | 4.6% | ||
| Q2 25 | 19.3% | 5.5% | ||
| Q1 25 | 22.7% | 3.3% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 2.5% | ||
| Q2 24 | 19.4% | 1.7% | ||
| Q1 24 | 18.5% | 1.9% |
现金转化率ACHCFN
| Q4 25 | — | 0.41× | ||
| Q3 25 | 2.02× | 1.07× | ||
| Q2 25 | 4.43× | 0.63× | ||
| Q1 25 | 1.37× | 0.91× | ||
| Q4 24 | 3.58× | 1.34× | ||
| Q3 24 | 2.39× | 1.07× | ||
| Q2 24 | 2.18× | 1.02× | ||
| Q1 24 | -4.21× | 1.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
